RE:RE:RE:RE:Someone Please Explainthe price of RVX IMO reflects two primary issues:
a) RVX is now a stock that trades with chinee stock market
b) FDA it seems as i read between the lines in the AIF is expecting the traditional 2 PIII trials before approval.
this makes sense and is quite problematic, 2 PIII trials is the SOP of the FDA particularly where there is a SoC. i am unsure how RVX will get around this issue as the PII trials were relatively lowly powered (not enough patients)...RVX is targeting for BoM i believe 250 events i wonder if they need to be bumping this up if they truly believe in the science and those very strong RRR's, as i suspect the only way to not do 2 PIII's is an overwhelmingly homerun BoM...one issue would be durability of the RRR, do the "tails" converge as time progresses say over 18 months????
ps i believe the US has recently passed some new drug bill which i believe "liberalizes" some of the classic FDA processes..if RVX were smart IMO they wait until that dust settles before finalizing anything (if they can)....